Artiva Biotherapeutics, Inc. Deferred Costs, Noncurrent
Artiva Biotherapeutics, Inc. (ARTV) had Deferred Costs, Noncurrent of $2.84 million as of 2024-06-30, per its 10-Q filed 2024-08-29.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCosts · last filed 2024-08-29
- 2024-06-30: Deferred Costs, Noncurrent $2.84M.
- 2023-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2024-06-30 | $2.84M 10-Q · filed 2024-08-29 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |